F182-0213 Screening compound: 4-[6-(3-phenyl-1,2,4-oxadiazol-5-yl)pyridazin-3-yl]morpholine

F182-0213 Screening compound: 4-[6-(3-phenyl-1,2,4-oxadiazol-5-yl)pyridazin-3-yl]morpholine
F182-0213 Screening compound: 4-[6-(3-phenyl-1,2,4-oxadiazol-5-yl)pyridazin-3-yl]morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound F182-0213
4-[6-(3-phenyl-1,2,4-oxadiazol-5-yl)pyridazin-3-yl]morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F182-0213

Molecular Formula

C16H15N5O2 (C16 H15 N5 O2)

Compound Name

4-[6-(3-phenyl-1,2,4-oxadiazol-5-yl)pyridazin-3-yl]morpholine

IUPAC name

4-[6-(3-phenyl-124-oxadiazol-5-yl)pyridazin-3-yl]morpholine

SMILES

C(COCC1)N1c(cc1)nnc1-c1nc(-c2ccccc2)no1

InChI

InChI=1S/C16H15N5O2/c1-2-4-12(5-3-1)15-17-16(23-20-15)13-6-7-14(19-18-13)21-8-10-22-11-9-21/h1-7H,8-11H2

InChI Key

QHSWNHMQMLULJW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27107272

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

309.33

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.612

Distribution Coefficient, logD

2.611

Water Solubility, LogSw

-2.69

Polar Surface Area

64.212

Acid Dissociation Constant (pKa)

24.54

Base Dissociation Constant (pKb)

4.10

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

F182-0213 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

GPCR Targeted Library (31838 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with F182-0213 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F182-0213?
Check Price and Availability of F182-0213, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F182-0213 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F182-0213
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F182-0213
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F182-0213 available by request